Matt Harmon and Justin Boone kick off our 'Teams that will shape the draft' series by looking at the teams that have multiple first round picks in this year's draft. Harmon and Boone do a deep dive on ...

Stopping GLP-1 weight loss and diabetes drugs for just six months can quickly erase any related benefits for cardiovascular health, researchers have said. A three-year study by Washington University ...

Please provide your email address to receive an email when new articles are posted on . Patients taking GLP-1s had a higher propensity to develop osteoporosis vs. matched controls. Patients taking GLP ...

Ella Langley has a lot of reasons to be excited. As the country star gears up for the release of her sophomore album, Dandelion, she took some time to celebrate landing two No. 1 songs with “Choosin’ ...

Tens of thousands of shoppers are reporting widespread problems using Amazon’s website, according to reports from outage tracker Downdetector. As of 3:45 p.m. ET on Thursday, March 5, reports of ...

Evidence continues to mount suggesting that GLP-1 drugs may help people cut back on cigarettes, drinking and opioid use. As the medications — which include semaglutide and tirzepatide — have grown in ...

As more patients take GLP-1 medications, it’s common for patient questions to arise about how alcohol consumption may affect the efficacy and side effects of these weight-loss medications. Proactive ...

Add Yahoo as a preferred source to see more of our stories on Google. Actress and comedian Mo'Nique Hicks is expressing her concern over the public using various GLP-1 drugs to lose weight. In an ...

This interview aired Jan. 22, 2026, and has been edited for clarity. Drugs like Wegovy, Ozempic, and more have skyrocketed in popularity, helping many people lose weight. But these GLP-1s may also ...

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

Companies on the fence about offering an employee benefits plan that covers GLP-1s may find the following data helpful: A report from risk consultation firm Aon, released Jan. 13, suggests workers’ ...

Elizabeth Cooney is a cardiovascular disease reporter at STAT, covering heart, stroke, and metabolic conditions. You can reach Liz on Signal at LizC.22. When endocrinologist Mary Elizabeth Patti looks ...